JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110803200 on March 18, 2002

J. Biol. Chem., Vol. 277, Issue 24, 21630-21638, June 14, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/24/21630    most recent
M110803200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, J. Y.
Right arrow Articles by Cho, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, J. Y.
Right arrow Articles by Cho, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Calmodulin Isoform-specific Binding Peptides from a Phage-displayed Random 22-mer Peptide Library*

Ji Young ChoiDagger §, Sang Hyoung LeeDagger §, Chan Young ParkDagger §, Won Do HeoDagger , Jong Cheol KimDagger , Min Chul KimDagger , Woo Sik ChungDagger , Byeong Cheol Moon, Yong Hwa CheongDagger , Cha Young KimDagger , Jae Hyuk YooDagger , Ja Choon KooDagger , Hyun Mi Ok, Seung-Wook Chi||, Seong-Eon Ryu||, Sang Yeol LeeDagger , Chae Oh LimDagger , and Moo Je ChoDagger **

From the  Division of Applied Life Science (BK21 Program), Dagger  Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Chinju 660-701 and the || Center for Cellular Switch Protein Structure, Korea Research Institute of Bioscience and Biotechnology, 52 Euh-eun-dong, Yusong, Daejon 305-333, Korea

Received for publication, November 12, 2001, and in revised form, March 15, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plants express numerous calmodulin (CaM) isoforms that exhibit differential activation or inhibition of CaM-dependent enzymes in vitro; however, their specificities toward target enzyme/protein binding are uncertain. A random peptide library displaying a 22-mer peptide on a bacteriophage surface was constructed to screen peptides that specifically bind to plant CaM isoforms (soybean calmodulin (ScaM)-1 and SCaM-4 were used in this study) in a Ca2+-dependent manner. The deduced amino acid sequence analyses of the respective 80 phage clones that were independently isolated via affinity panning revealed that SCaM isoforms require distinct amino acid sequences for optimal binding. SCaM-1-binding peptides conform to a 1-5-10 ((FILVW)XXX(FILV) XXXX(FILVW)) motif (where X denotes any amino acid), whereas SCaM-4-binding peptide sequences conform to a 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif. These motifs are classified based on the positions of conserved hydrophobic residues. To examine their binding properties further, two representative peptides from each of the SCaM isoform-binding sequences were synthesized and analyzed via gel mobility shift assays, Trp fluorescent spectra analyses, and phosphodiesterase competitive inhibition experiments. The results of these studies suggest that SCaM isoforms possess different binding sequences for optimal target interaction, which therefore may provide a molecular basis for CaM isoform-specific function in plants. Furthermore, the isolated peptide sequences may serve not only as useful CaM-binding sequence references but also as potential reagents for studying CaM isoform-specific function in vivo.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CaM1 is a ubiquitous intracellular Ca2+ receptor involved in transducing a variety of extracellular signals (1-3). In contrast to mammals, many plant species belong to a CaM multigene family that encodes various CaM isoforms (4-5). Over 30 genes encoding CaM isoforms are found in the complete nucleotide sequence of Arabidopsis thaliana.2 CaMs function by modulating or regulating the activities of their target proteins (CaM-binding proteins). More than 30 CaM-binding proteins have been identified, including enzymes such as kinases, phosphatases, and nitric-oxide synthase, as well as receptors, ion channels, G-proteins, and transcription factors (7-9). Plants seem to have evolved a unique repertoire of CaM targets whose homologues in animals do not appear to be modulated by CaMs. The shear number of CaM isoforms and the diversity of CaM targets imply that these proteins in plants likely modulate a broad spectrum of processes.

CaM is dumbbell-shaped with the N- and C-terminal globular domains separated by a flexible central helix. Each lobe contains two helix-loop-helix Ca2+-binding motifs referred to as "EF-hands" that are interconnected by a small beta -sheet between the two Ca2+-binding loops (10). Ca2+ binding to CaM induces conformational changes that expose hydrophobic amino acid residues on the surface of both lobes. This creates two hydrophobic pockets that are important for target peptide binding. CaM binds to a large number of proteins through interactions with specific CaM-binding domains. Therefore, one of the most intriguing questions concerning the interaction of CaM with target proteins is: how does a phylogenetically conserved protein like CaM specifically interact with so many different target sites? The determination of the three-dimensional structures of the CaM-peptide complexes greatly aided in answering this question (11-15).

Many known Ca2+-dependent CaM-binding proteins possess a region that is often characterized by an amphipathic helix consisting of ~20 amino acid residues. This region contains two hydrophobic/aromatic residues that are separated by 12 intervening residues that anchor the peptide to the two lobes of CaM (2). However, sequence analyses based upon this criteria do not always identify the CaM-binding region of a protein, and therefore, the CaM-binding regions of target proteins do not always fit these criteria. Furthermore, the presence of a novel class of CaM-binding proteins that assume a non-helical conformation in the CaM complex has been suggested (16). The CaM-binding domains of these proteins are characterized by the dominance of basic amino acids in contrast to the canonical motif in which hydrophobic amino acids are dominant. An attempt was made to examine the elements common to the many reported CaM-binding regions from different proteins. From sequence comparisons of CaM-binding peptides and CaM-binding domains within the CaM-regulated proteins, three classes of CaM-binding motifs have emerged (17). They include a modified variant of the IQ motif as a consensus for Ca2+-independent binding and two related motifs for Ca2+-dependent binding, termed 1-8-14 and 1-5-10 (based on the conserved hydrophobic residues within these motifs). Based on these structures and sequence information, a web-based data base is available for quickly searching for a potential CaM-binding site in a given protein sequence (18).

In plant cells, multiple CaM genes code for numerous CaM isoforms in wheat (19), potato (20), Arabidopsis (21), and soybean (22). We have recently cloned five CaM isoforms from soybean (SCaM-1-5). Although some of these isoforms (i.e. SCaM-1-3) are more than 90% identical to mammalian CaM, two (SCaM-4 and SCaM-5) exhibit only a 78% homology with SCaM-1 and are therefore the most divergent isoforms reported thus far in the plant and animal kingdoms. SCaM-4 is considered a bona fide CaM isoform based on the following characteristics. At primary structure level, SCaM-4 has conserved four putative EF-hands and a central linker region, hallmarking structural features of CaM (22). In addition, most of amino acid exchanges occur outside EF-hands, and the number of total amino acid residues are also conserved (148 amino acid residues for SCaM-1 and mammalian CaM, and 149 amino acid residues for SCaM-4 (22)). When compared with the preferred consensus amino acid residues of EF-hands derived from known Ca2+-binding proteins (23), the residues in all four Ca2+-binding loops of SCaM-4 conform to the consensus (Fig. 1), suggesting that SCaM-4 can bind four Ca2+ molecules. All SCaM isoforms including SCaM-4 are ubiquitously expressed in various plant tissues and show similar subcellular localization patterns to the highly conserved SCaM-1 (22, 24). Intriguingly, the cellular level of SCaM-4 rapidly rises upon specific stimuli such as pathogen infection in the same cells constitutively expressing SCaM-1 (25). Furthermore, SCaM-4 has the ability to modulate activity of many CaM-dependent enzymes. However, SCaM-4 has distinguished ability from SCaM-1 in the activation of CaM target enzymes, which can be categorized into three different types (22, 26-29) as follows: 1) enzymes activated equally by both SCaM-1 and SCaM-4 (e.g. phosphodiesterase (PDE), plant Ca2+-ATPase, plant glutamate decarboxylase, and CaM-dependent protein kinase II); 2) enzymes activated only by SCaM-1 (e.g. calcineurin, myosin light chain kinase, red cell Ca2+-ATPase, and plant NAD kinase); and 3) enzymes activated only by SCaM-4 (e.g. nitric-oxide synthase). SCaM-1 and SCaM-4 also exhibit differences in their Ca2+ concentration requirements for target enzyme activation (28). Studies defining CaM-binding sequences and analyzing their interactions with CaM have shed light on the specificity of the interactions between CaM and the particular target molecules.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Comparison of amino acid sequences of four EF-hands from SCaM-1, SCaM-4, and bovine brain CaM (B-CaM). Consensus shows the most frequently observed amino acid residue in each position of the Ca2+-binding loop region of EF hand, which is derived from the comparison of known Ca2+-binding proteins (23). Underlined amino acid residues indicate higher than 70% conservation. Ca2+-binding ligands are denoted by asterisks, and residues conformed to the consensus are indicated by boldface letters.

Here we have adapted an approach for defining the SCaM-1 and SCaM-4-binding peptide sequences using a random peptide bacteriophage display library. Bacteriophage display and affinity selection of phage-displayed peptide libraries, a technique based on screening a library of foreign peptides displayed on the surface of M13 bacteriophage, has proven to be a very useful tool for characterizing a number of protein-protein interactions. Due to the physical linkage of the expressed peptide with its genetic sequence, libraries numbering from 108 to 1010 peptides have been rapidly screened for a wide variety of applications. This useful tool has been used to map antibody epitopes and to discover peptide ligands for membrane receptors and cytosolic proteins in recent years (30). In this work, we have searched SCaM isoform (SCaM-1 and -4)-favored peptide sequences from a phage display library, and we defined novel SCaM-1- and SCaM-4-specific binding sequences. Furthermore, we have analyzed the interactions between SCaM-1 and SCaM-4 and their respective binding peptides using a variety of biochemical techniques including gel overlay, gel mobility shift, fluorescence spectroscopy, and phosphodiesterase competition assays. Our data show that SCaM isoforms possess different sequences for optimal binding to specific targets. This may provide a molecular basis for CaM isoform-specific function in plants.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of a Random 22-mer Phage Library-- The phagemid vector pCANTAB5E (Amersham Biosciences) was modified to construct a vector for our library (Fig. 2A). Two oligonucleotides (5'-CCGGCCGGCGATATCAGCGGC-3' and 5'-GGCCGCGCCGCTGATATCGCCGGCCGGCT-3') were mixed, heated to 75 °C for 10 min, and allowed to hybridize by cooling slowly at room temperature for 30 min. The hybrids were inserted at the NotI and SfiI site of pCANTAB5E to introduce NotI and EcoRV sites and a sequence coding for junction amino acid residues. The resulting phage peptide library vector was named pCANTAB5F. These vectors were digested with NotI and EcoRV to clone double-stranded DNA coding for random peptides. This process is shown in Fig. 2B. Single-stranded DNA encoding 22-residue random peptides (5'-(NNK)22GCGGCCGCAGGTGCGC-3') and one oligonucleotide (5'-GCGCACCTGCGGCCGC-3'), in which N is A, C, G, or T (equimolar), and K is C or T (equimolar) were hybridized and converted into double-stranded DNA using Klenow DNA polymerase. The DNA was cut by NotI to produce one blunt end and one NotI site and then ligated into pCANTAN5F. The resulting DNA sequence and amino acid sequence of the N-terminal region of gpIII are shown in Fig. 2C. Twenty electroporations, each using 0.5 µg of the DNA constructed as above and 100 µl of electrocompetent Escherichia coli TG1 cells, yielded 4.2 × 108 transformants producing infectious phages. The helper phage M13K07 was used to produce a phage library from the bacteria harboring library phagemids.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Construction of the random peptide library. Recognition sequences and restriction sites of enzymes are indicated by boxes and edged lines, respectively. The letter N stands for an equal mixture of A, G, C, and T, and K stands for an equal mixture of Cys and Thr. A, procedure is described for construction of the peptide library vector pCANTAB5F. The amino acid sequence at the N terminus of gpIII and the corresponding DNA sequences are shown. Boldface letters correspond to the substituted or inserted residues. B, procedure is depicted for construction of double-stranded DNA coding for random peptides. C, amino acid sequence is listed for the random peptide, indicated as X22. The corresponding DNA sequence is also shown.

Isolation of SCaM Isoform Binding Phages by Biopanning-- The library was screened either with SCaM-1 or SCaM-4 isoforms (22) coated on 35 × 10-mm plastic Petri dishes. These Petri dishes were coated with SCaM isoforms by incubating them with 1 ml of the SCaM protein (100 µg/ml in TBS) for 1 h at 37 °C. The residual binding capacity of the dish was blocked with 0.1% BSA. About 2.3 × 1011 colony-forming units of the phage library in TBS (150 mM NaCl in 50 mM Tris-HCl, pH 7.5), 0.1% Tween 20 were preincubated with 0.1% BSA for 1 h at room temperature to remove BSA-binding phages and were bound to the SCaM-coated dishes by incubating them overnight at 4 °C. The plates were washed ten times for 5 min with 1 ml of TBS, 0.1% Tween 20 to remove unbound phages. Phages bound to SCaM-1 or SCaM-4 were eluted in TBS, 0.1% Tween 20 with 2 mM EGTA. The eluted phages were amplified by infecting logarithmic phase E. coli TG1. The helper phage M13K07 was introduced into infected cells to produce phages. The resulting phages were subjected to an additional two rounds of biopanning. SCaM-1 or SCaM-4-binding phages obtained by three rounds of the selection process were plated with E. coli TG1 to raise colonies. Each clone was grown in 1 ml of 2× YT medium supplemented with 100 µg/ml ampicillin at 37 °C, shaking to a late log phase. After adding the Helper phage M13K07, the culture was further incubated overnight, and a clear phage supernatant was collected following a 5-min centrifugation. Each of the phages was transferred into a 96-well microtitration plate coated with the SCaM-1 and -4 isoforms as in the above biopanning method. These were tested for the binding affinities of the selected phages to SCaM-1 and -4 by enzyme-linked immunosorbent assay using an HRP-conjugated anti-M13 antibody (Amersham Biosciences). The reaction of HRP with 2',2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) was quantified by measuring the absorbance at 410 nm in a microplate spectrophotometer.

Expression of Recombinant GST Peptide Fusion Proteins in E. coli-- Inserts of selected clones were amplified by PCR using modified primers both upstream and downstream of the gene III sequence (5'- TTAGCCATGGCTTTCTATGCGGCCCAG-3' and 5'-AGCGGACCCGGGTACGGCACCGGCGCA-3'), where the underlined nucleotides represent the SmaI and NcoI recognition sequence. PCR was performed using a temperature program consisting of 25 cycles of 1 min at 95 °C, 1 min at 55 °C, and 1 min at 72 °C, followed by one cycle of 5 min at 72 °C. After amplification, the PCR products were digested with SmaI and NcoI and cloned in SmaI- and NcoI-cleaved GST fusion vector, pGEX-KG (31). The ligated DNAs were used to transform E. coli BL21 cells. DNA was prepared as above from the cultures of individual colonies, and recombinants were identified by digestion with SmaI and NcoI and confirmed by DNA sequence analysis. Recombinant DNA techniques including transformations, plasmid preparations, gel electrophoresis, ligations, and enzyme digestions were all carried out according to Sambrook et al. (32). Purification of DNA from agarose gels was performed with a QIAEX II purification kit (Qiagen).

For the preparation of GST fusion proteins, transformants were grown in liquid cultures with ampicillin selection to an optical density of 0.5 at 600 nm. 1 mM isopropyl-1-thio-beta -D-galactopyranoside was then added, and the cultures were further incubated for 18 h at 37 °C. Cells were collected by centrifugation and stored at -20 °C or less until used. Frozen cells were thawed on ice and resuspended in buffer M (20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 5 mM 2-mercaptoethanol, 2 mM phenylmethylsulfonyl urea, 0.1 mM p-aminobenzamidine), and the cell suspensions were sonicated for 1 min at a 20% pulse. After clearing the lysate by centrifugation at 15,000 rpm for 10 min at 4 °C, the supernatant (designated as the crude CaM-PEP preparation) was used for the binding assays.

CaM Gel Overlay Assay-- To prepare horseradish peroxidase (HRP)-conjugated CaMs, we conjugated SCaMs with a maleimide-activated HRP using the EZ-Link maleimide-activated HRP conjugation kit (Pierce) according to the manufacturer's instructions. Before conjugation, SCaMs were incubated in 50 mM Hepes, pH 7.0, 0.1 M dithiothreitol at 55 °C for 1.5 h to reduce cysteine residues. The reduced SCaMs were washed and concentrated in degassed phosphate-buffered saline buffer using Centricon C10s (Amicon). After conjugation, the efficiency of SCaMs conjugation to HRP was determined by SDS-PAGE. Conjugation efficiency was usually greater than 90%. Unconjugated residual CaM was removed by gel filtration. CaM gel overlays were performed as described previously (33). Ten µg of GST fusion protein was separated on an 11% SDS-polyacrylamide gel.

DNA Sequencing-- DNA sequencing was carried out using primers (5'-CCATGATTACGCCAAGCTTTGGAGCC-3' and 5'-GTAAATGAATTTTCTGTATGAAG-3') and an Applied Biosystems automatic sequencer (PerkinElmer Life Sciences).

Peptide Synthesis-- Peptides (Pep A, APAHALFHWGVLGSLIRLVFLS, and Pep B, CNRLLLRSLRYWGYVVLSALRL) were synthesized at the Peptide Synthesis Facility (Peptron, DaeJun, South Korea) using an Applied Biosystems model instrument. Peptides were desalted and purified by reverse-phase high pressure liquid chromatography using a C18 column, and their amino acid sequences were analyzed.

Gel Mobility Shift Assays-- The abilities of the synthetic peptides (i.e. Pep A and B) to bind to the SCaM-1 and SCaM-4 isoforms were examined by the relative mobility shifts of the CaM-peptide complexes using 4 M urea polyacrylamide gel electrophoresis in the presence of the peptide and 0.1 mM CaCl2 or 2 mM EGTA. Urea gels contained 13% acrylamide, 4 M urea, 0.375 M Tris-HCl, pH 8.8, and 0.1 mM CaCl2, or 2 mM EGTA and were run at a constant voltage of 100 V in electrode buffer consisting of 25 mM Tris-HCl, 192 mM glycine, pH 8.3, and 0.1 mM CaCl2, or 2 mM EGTA. The SCaM-1 or SCaM-4 isoform and increasing concentrations of Pep A and B (molar ratio: 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, and 2.5) were incubated at room temperature for 1 h in 100 mM Tris-HCl, pH 7.2, 4 M urea, and 0.1 mM CaCl2, or 2 mM EGTA. Glycerol (50%) with tracer bromphenol blue was added before the samples were loaded onto the gel.

Fluorescence Spectroscopy-- The changes in the microenvironments of the peptide Trp residues upon binding to SCaM were monitored by fluorescence spectroscopy using a PerkinElmer Life Sciences LS50 luminescence spectrometer. The excitation and emission slit widths were 2 nm, and emission spectra scanning was carried out at 10 nm/min with a 1-cm path length cuvette. The Trp residues of Pep A and B incubated in Ca2+ buffer (50 mM Mops, pH 7.5, 0.1 M KCl, 0.1 mM CaCl2) or in EGTA buffer (50 mM Mops, pH .5, 0.1 M KCl, 2 mM EGTA) at room temperature for 30 min were excited at a 295 nm excitation wavelength, and the fluorescence emission spectra in the range 295-560 nm were recorded. An excitation wavelength of 295 nm was used to decrease Tyr fluorescence in SCaM. SCaM was added to the same cuvette from a highly concentrated stock solution to maximize the dilution effects.

Circular Dichroism-- CD spectra were obtained on a Jasco J-720 spectropolarimeter using a 1-mm cell at 25 °C. The peptide concentration used for CD measurements was 50 µM, and the solutions included 10 mM Tris-HCl, pH 7.5, and 50% 2,2,2-trifluoroethanol (TFE) (v/v). Secondary structure contents were calculated using the Circular Dichroism Deconvolution program (34).

Phosphodiesterase (PDE) Competition Assay-- Cyclic nucleotide PDE assays were performed using commercially available bovine heart CaM-deficient PDE (Sigma). The initial 100-µl reaction volume contained buffer (100 mM imidazole HCl, 2.56 mM cAMP, 5.13 mM MgSO4, 1.28 mM CaCl2) and varying concentrations of SCaMs (5-200 nM) in the presence (100 nM of either Pep A or Pep B) or absence of peptides. The reaction was started by the addition of PDE (0.3 milliunits/µl). The basal level of enzyme activity was determined in the absence of SCaM, and stimulated activity was determined in the presence of either SCaM-1 or SCaM-4 and CaCl2. After an incubation at 37 °C for 30 min, the reactions were stopped by placing the reaction tubes in a boiling water bath for 5 min and then on ice for 2 min. Following a brief centrifugation step, 50 µl of alkaline phosphatase (10 units) was added, and the samples were incubated for 10 min at 37 °C. The reactions were stopped by adding 500 µl of 10% trichloroacetic acid. After vortexing, the precipitates were pelleted, and the supernatants (400 µl) were transferred to new tubes. One ml of phosphate reagent (22) was then added, and samples were incubated for 15 min at 37 °C and assayed for Pi content at OD660. The dissociation constants (Kd) of SCaM-1 and -4 for Pep A and B were calculated from the concentration of SCaM (nM) required to obtain half-maximal PDE activity either in the presence (100 nM) or absence of the peptides. The following equation (35) was used to calculate the dissociation constants: Kd = ([Pt] + K - [CaM])K/([CaM] - K), where [Pt] represents the total concentration of peptide added, and [CaM] and K are the concentrations of CaM required to obtain half-maximal activation of PDE in the presence or absence of peptides, respectively. The Kd for Pep A or B binding to SCaM-1 or -4 was calculated using the following values: [Pt] = 100 nM, K = 9.7 nM (for Pep A) or 10.5 nM (for Pep B) (calculated from the SCaM-1 or -4 activation curves in the absence of Pep A or B), [SCaM] = 33.6 nM (for Pep A) or 37.4 nM (for Pep B) (calculated from the SCaM activation curve in the presence of 100 nM Pep A or B).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction and Characterization of the Random 22-mer Peptide Phage Display Library-- The 22-mer phage display random peptide libraries were constructed using a modified pCANTAB vector, as described in Fig. 2. Random peptides of 22 amino acids in length are expressed at the N terminus of the M13 protein III bacteriophage. Initial transformation of the library produced 4.8 × 108 independent clones and subsequent amplification yielded 2.3 × 1011 pfu/ml. To confirm the diversity of peptide sequences in the library, we randomly picked 80 individual phage clones and determined nucleotide sequences of random peptide regions. In Fig. 3A, the distribution of amino acids in the 22-mer random peptide library is reported as a percentage of the total. All amino acids were uniformly distributed in this library, taking into account the bias inherent in the codon usage ratio. The distribution of amino acid types that appears at each residue position of the sequenced inserts is shown graphically in Fig. 3B. Acidic (Asp and Glu), basic (Lys, Arg, and His), polar (Ser, Thr, Cys, Tyr, Asn, and Gln), and nonpolar amino acids (Gly, Ala, Val, Leu, Ile, Pro, Phe, Trp, and Met) are relatively proportional to their presence in the genetic code and generate not only linear sequence diversity but also the biochemical diversity desired in a library for screening.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Amino acid distribution in the 22-mer random peptide library. A, a total of 80 peptide sequences from the 22-mer random library was obtained and analyzed as described under "Experimental Procedures." The percentage of each total amino acid was determined. B, frequency and positional distribution are listed for the amino acid types in the 22-mer random peptide library. The amino acids were divided into acidic (Asp and Glu), basic (Lys, Arg, and His), nonpolar (Gly, Ala, Val, Leu, Ile, Pro, Phe, Trp, and Met), and polar (Ser, Thr, Cys, Tyr, Asn, and Gln) species. The frequency of each amino acid type at each residue position is indicated as follows: acidic, dotted bars; basic, open bars; nonpolar, hatched bars; and polar, filled bars.

Isolation of SCaM-1- and SCaM-4-binding Peptides-- In an effort to study the binding sequence preferences of the SCaM-1 and SCaM-4 isoforms, we screened a phage display peptide library by biopanning with purified SCaM-1 and SCaM-4 proteins, respectively (see under "Experimental Procedures"). Briefly, SCaM-1 or SCaM-4 proteins immobilized on the surface of plastic Petri dishes were incubated with phages in the presence of Ca2+. Bound phages were eluted with EGTA after extensive washing. After three rounds of selection, isolated phage clones were tested for specific binding to SCaM-1 or SCaM-4 via an enzyme-linked immunosorbent assay-based assay (see "Experimental Procedures"). Approximately 90% of the isolates exhibited strong SCaM-1- or -4-binding activity (data not shown). Each of the 80 independent phages reacting strongly in the enzyme-linked immunosorbent assay were selected from the SCaM-1- and SCaM-4 biopanning, and their nucleotide sequences were determined. In Fig. 4, their deduced amino acid sequences are shown in random peptide regions, which are aligned to reveal consensus sequences. For convenience, we designated SCaM-1-binding peptide sequences as the alpha -series and SCaM-4-binding peptides as the beta -series. Despite the considerable sequence diversity observed among these clones, their careful alignment yields two distinct binding motifs. Based on the positions of conserved hydrophobic residues, SCaM-1-binding peptides can be fit into a 1-5-10 motif, possessing a consensus sequence of ((FILVW)XXX(FILV)) (where X denotes any amino acid). In contrast, SCaM-4-binding peptides conformed to a 1-8-14 motif of ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)). In both cases, most of these peptide sequences contain one or more basic amino acid residues, which results in an overall positive net charge for these peptides.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   Deduced amino acid sequences derived from the phage display library by affinity selection with SCaM-1 (A) or SCaM-4 (B). Phages from a 22-mer random peptide display library were subjected to three rounds of selection on SCaM-1 or SCaM-4 affinity panning. Each of the 80 independent phages selected for its strong enzyme-linked immunosorbent assay signal was selected from SCaM-1- or SCaM-4 biopanning. Their nucleotide sequences were determined, and the deduced amino acids are compared. Boldface residues indicate the three hydrophobic amino acids that are grouped into one of two types (the 1-5-10 ((FILVW)XXX(FILV)XXXX(FILVW)) motif represents the SCaM-1-binding peptides, and the 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif represents the SCaM-4-binding peptides) based on the positions of conserved hydrophobic residues. The frequency of appearance (n) and electrostatic charge of each of the isolates is indicated as shown.

Identification of SCaM-1- or -4-specific Peptides by Gel Overlay Assay-- To verify the specificity of SCaM-binding phage isolation using biopanning, a CaM gel overlay assay was performed (24). First of all, three of the most frequently isolated peptides obtained from each of the SCaM-binding phages (i.e. alpha 1, alpha 2, and alpha 3 for SCaM-1 and beta 1, beta 2, and beta 3 for SCaM-4) were expressed as GST fusion proteins using the vector pGEX-KG (30). As shown in Fig. 5, these GST fusion proteins exhibited molecular masses of ~29 kDa by SDS-PAGE, consistent with the predicted values of ~3 kDa for the SCaM peptide plus ~26 kDa for the GST protein. In the gel overlay assays, all alpha  peptide fusion proteins exhibited positive signals with SCaM-1-HRP (Fig. 5A), whereas SCaM-4-HRP resulted in no signal. Conversely, for the beta  peptide fusion proteins, only SCaM-4-HRP exhibited positive binding. Interestingly, CaM binding signals for these fusion proteins correlated with their frequency of isolation in the biopanning. For example, alpha 1 and beta 1, the most frequently isolated sequences for SCaM-1 and SCaM-4 binding, respectively, produced the strongest signals among the tested alpha  and beta  peptides in the gel overlays (Fig. 5, A and B). In either case, the negative control (i.e. GST protein alone) exhibited no binding to either of the SCaM-HRP probes. In addition, no significant signal was detected when the gel overlay assays were performed in the presence of an EGTA-containing buffer (data not shown). Thus, these results indicate that these peptide sequences specifically bind to the corresponding SCaM-1 or SCaM-4 in a Ca2+-dependent manner.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 5.   SCaM gel overlay of isolated peptides. The GST fusion proteins were prepared as described under "Experimental Procedures." Equal amounts (10 µg) of total E. coli protein extracts were subjected to SDS-PAGE (11% gel), and stained by Coomassie Brilliant Blue (left 1st panels). The protein gels were transferred to nitrocellulose membranes and probed with anti-GST antibody (Ab) to detect the expression of GST fusion peptides (2nd panels from left) and probed further with either SCaM-1-HRP (3rd panels from left) or SCaM-4-HRP (right panels). The bound SCaM-1-HRP or SCaM-4-HRP was detected using an ECL system (Amersham Biosciences). M indicates protein molecular weight marker, A shows the SCaM-1-favored peptides, and B shows the SCaM-4-favored peptides.

Gel Mobility Shift Assays-- The gel overlay assays confirmed the binding of SCaM to the isolated peptide sequences. However, they did not provide quantitative information for these interactions. To examine further the SCaM-binding specificity of the isolated peptide sequences, the most frequently isolated peptide sequence was selected from each SCaM-1 or SCaM-4-binding peptide sequence. These are designated as Pep A (APAHALFHWGVLGSLIRLVFLS) and Pep B (CNRLLLRSLRYWGYVVLSALRL), respectively. The synthesized peptides were then tested by gel mobility shift to assess their interactions with the SCaM isoforms. Complexes formed between the SCaM isoforms and either Pep A or Pep B were confirmed by gel electrophoresis in the presence of 4 M urea. Urea was used since it dissociates low affinity and nonspecific complexes, leaving only the higher affinity and higher specificity complexes behind. As the ratio of peptide to Ca2+-SCaM increased, we observed a band shift due to the formation of a complex between the peptide and Ca2+-SCaM (Fig. 6, A and D). In the absence of peptide, SCaM migrates as a single band (data not shown). When the ratio of peptide to SCaM was equal, a mobility shift was observed for nearly all of the SCaM proteins. At a peptide to SCaM molar ratio of 1.5, virtually no free SCaM was detected. Taken together, these observations indicate that the peptides bind to the Ca2+-bound SCaM isoforms at a 1:1 molar stoichiometry. This is consistent with the previous observation (36) that most of the well characterized CaM-binding peptides, including peptides derived from myosin light chain kinase, constitutive nitric-oxide synthase, and CaM-dependent protein kinase I form a 1:1 complex with Ca2+-CaM. No mobility shift was observed when 5 mM EGTA was added to the samples, indicating that the interactions between the SCaM isoforms and the peptides are Ca2+-dependent (Fig. 6, B and E). Interestingly, we could detect neither a SCaM-1-Pep B nor a SCaM-4-Pep A complex in the mobility shift assay (Fig. 6, C and F). These results suggest that in the presence of Ca2+, Pep A and Pep B form a 1:1 complex with SCaM-1 and SCaM-4, respectively. Additionally, these peptides possess a certain degree of specificity toward the SCaM isoforms.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Gel mobility shift assay for peptide-SCaM isoform complexes. Complex formation between SCaM isoforms and either Pep A or Pep B was determined in the presence of either 0.1 mM CaCl2 or 2 mM EGTA. Purified SCaM-1 or SCaM-4 was incubated with increasing amounts of Pep A or B (Pep A or B versus SCaM-1 or -4 molar ratios are indicated), and then samples were separated by nondenaturing PAGE in the presence of 4 M urea. The gels were stained with Coomassie Brilliant Blue. A indicates SCaM-1 + Pep A + Ca2+; B indicates SCaM-1 + Pep A + EGTA; C indicates SCaM-4 + Pep A + Ca2+; D indicates SCaM-4 + Pep B + Ca2+; E indicates SCaM-4 + Pep B + EGTA; and F indicates SCaM-1 + Pep B + Ca2+. The arrows in A and D indicate the SCaM-1-Pep A or SCaM-4-Pep B complexes, respectively. Free peptide is not apparent because it had run out of the gels by the time electrophoresis was stopped.

Trp Fluorescence Emission Spectra-- The peptide interactions with SCaM-1 or -4 were also examined by taking advantage of the intrinsic fluorescence of the Trp residue in the peptide sequences. Fluorescence spectroscopy is a convenient method for determining the SCaM-peptide complex. The peptides have excitation and emission wavelengths of 295 and 295-560 nm, respectively. The maximum emission of the peptide in the absence of CaM occurred at 353 nm (Fig. 7). Upon addition of SCaM-1 or -4 to the reaction mixtures containing Pep A or Pep B in the presence of Ca2+, the maximum fluorescence emission of the synthetic peptides shifted to shorter wavelengths (i.e. for SCaM-1 it was from 353 to 333 nm and for SCaM-4 it was from 353 to 335 nm) and exhibited ~5-fold increase in intensity. This relatively large blue shift indicates that the Trp residues were in a hydrophobic environment such as the interior of SCaM, which is typical for CaM-binding peptides (37). The addition of 2 mM EGTA to the same reaction mixture completely reversed the shift in the emission spectrum (Fig. 7). These results revealed that each of the SCaM peptides bind directly to its corresponding SCaM isoform.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7.   Trp fluorescence spectra of peptide binding to SCaM isoforms. Rp fluorescence spectra were measured in the presence of Ca2+ or EGTA using a PerkinElmer Life Sciences LS50 luminescence spectrometer. An excitation wavelength of 295 nm was used to reduce Trp fluorescence from SCaM-1 (A) and SCaM-4 (B). SCaM-1 or -4 (2.5 µM) was added in a solution containing 1.9 µM Pep A or B in the presence of either 0.1 mM Ca2+ or 2 mM EGTA.

Circular Dichroism Spectra-- To examine the molecular basis of the binding specificity for the plant CaM isoforms, we characterized the secondary structures of the model peptides. Because shorter peptides tend to exist as flexible coils in pure water, we determined the secondary structures of the model peptides in the presence of 50% TFE, a compound that stabilizes secondary structures (38). In Fig. 8, the CD spectra for Pep A and Pep B obtained at 25 °C are presented. As can be seen, the spectra are very similar to each other. Both contain a minimum at 206-208 nm with a shoulder at around 222 nm, indicating the dominant presence of alpha -helices. From the CD spectra, the alpha -helix contents of Pep A and Pep B are estimated to be 72 and 76%, respectively. Thus, both Pep A and Pep B are likely to bind CaM isoforms as helices. In addition, in their SCaM-1-bound forms, both peptides showed increases in their alpha -helical content, further supporting this theory (data not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   CD spectra of Pep A and Pep B. CD spectra of Pep A () and Pep B (····) were measured in 50% TFE (v/v). Five consecutive scans (250-200 nm) for each sample were averaged to generate a spectrum.

Peptide-dependent Inhibition of CaM-activated PDE Activity-- Finally, the relative affinities of Pep A and Pep B for the SCaM isoforms were determined by using a competition assay for PDE, an enzyme that is activated equally by both SCaM-1 and SCaM-4 (22). In Fig. 9, A and B, the effect of increasing peptide concentrations on PDE activity is shown for a fixed concentration (120 nM) of SCaM-1 or SCaM-4, a concentration sufficient for the maximal activation of PDE. A gradual decrease in PDE activity was observed with increasing concentrations of the relevant peptides. Half-maximal inhibition of PDE activation by SCaM-1 and SCaM-4 was obtained at ~120 nM Pep A and ~80 nM Pep B, respectively. Up to a concentration of 600 nM, Pep A had no effect on the activation of PDE by SCaM-4 and a concentration of more than 1 µM was required to reach half-maximal inhibition. Pep B, on the other hand, was a slightly more potent inhibitor of PDE activation by SCaM-1, inhibiting at concentrations above 400 nM, and although similar to Pep A, half-maximal inhibition was not reached at concentrations below 1 µM. To determine Kd values for these peptides in the activation of PDE by SCaMs, the CaM dose-dependent activation of PDE was determined in the presence (100 nM) or absence of the peptides (Fig. 9, C and D). The activation curves shifted to the right in the presence of the peptides, indicating a competition occurring between PDE and the peptides for the SCaM isoforms. The Kd values for Pep A and Pep B for their inhibition of the activation of PDE by SCaM-1 or SCaM-4 was determined to be 31.0 and 28.5 nM, respectively (Fig. 9, C and D). These experiments suggest that Pep A and Pep B have at least a 10-fold specificity for SCaM-1 and SCaM-4, respectively.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of Pep A and Pep B on the activation of PDE by SCaM isoforms. The dose-dependent inhibitions of PDE activity by Pep A and Pep B are shown. The inhibitory activities were measured in the presence of Ca2+ and a fixed concentration (120 nM) of SCaM-1 (A) or SCaM-4 (B) with increasing concentrations of Pep A or Pep B. PDE activity was measured in the presence of varying concentrations of SCaM-1 or SCaM-4 and either in the presence or absence of fixed concentrations (100 nM) of Pep A (C) or Pep B (D). Results are shown as the means obtained from three independent assays (n = 3).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have shown previously (22, 26-28, 33) that SCaM isoforms exhibit differences in their abilities to activate target enzymes. Importantly, some CaM isoforms competitively inhibit the activation of certain enzymes by other CaM isoforms, exhibiting a reciprocal regulation of target enzymes (26, 28). In these in vitro enzyme assays, the SCaM isoforms often possessed significantly different affinities for a given enzyme. For example, with the activation of plant Ca2+-ATPase, SCaM-1 has ~20-fold higher affinity than SCaM-4 (28). Furthermore, in gel overlay assays of various plant CaM-binding proteins, these isoforms exhibited different binding intensities, suggesting that different CaM isoforms might require distinct primary sequences for optimal target binding (24). In this investigation, in which we took advantage of a phage-displayed random peptide library, we identify the peptide sequences that interact with specific SCaM isoforms. Surprisingly, two distinct families of peptides that specifically bind to SCaM-1 or SCaM-4 isoforms in a Ca2+-dependent manner were identified in this study. These peptides fit into a 1-5-10 ((FILVW)XXX(FILV)XXXX(FILVW)) motif for the SCaM-1-binding peptides and a 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif for the SCaM-4-binding peptides. Rhoads and Friedberg (17) originally identified these motifs as Ca2+-dependent brain CaM-binding sequences, based upon the positions of conserved hydrophobic amino acid residues. These hydrophobic residues play an important role in anchoring peptides to target binding pockets of CaM via a hydrophobic interaction. It is also noteworthy that these Ca2+-dependent CaM-binding motifs require basic residues, which are important in stabilizing the binding interaction by forming salt bridges. Consistent with this, all of the isolated peptides in this study were determined to be basic.

It is quite remarkable that plant CaM isoforms exhibit differing optimal sequence preferences for their target interactions in vitro. This is most likely due to structural differences between CaM isoforms. For example, SCaM-1 and SCaM-4 are ~22% different in regard to their primary amino acid sequences. What is the significance of this finding in terms of the function of CaM in plant cells? One intriguing possibility is that certain CaM isoforms may require specific binding targets thereby leading to unique cellular responses. This is consistent with the idea that these CaM isoforms evolved independently following segregation from a progenitor CaM, as predicted from phylogenetic analyses of these CaM isoforms (22). However, we should also point out that these isolated peptides could be the optimal binding sequences for given CaM isoforms, which are not found in nature. Indeed, in CaM gel overlay assays using plant cell extracts, we could hardly find binding proteins specific for the CaM isoforms (24). In addition, so far none of the enzymes tested in vitro in our laboratory exhibit specific binding to particular CaM isoforms. Furthermore, the differences in binding affinity between Pep A and Pep B to the SCaM isoforms were no greater than 10-fold. Therefore, it is reasonable to speculate that a large number of CaM-binding proteins bind to both isoforms, given a certain degree of affinity differences, and therefore only a few CaM isoform-specific binding proteins may exist in plants.

We reported previously that SCaM isoforms are different in their abilities to activate various target enzymes (28, 33). We examined whether there is a correlation between the differential target binding preferences for the activation profiles of SCaMs. Interestingly, in the case of alpha -CaMKII, which has a 1-5-10 CaM-binding motif, the 1-5-10-favoring SCaM-1 activated this enzyme and at a much lower concentration than SCaM-4 (~10-fold less, Kact 22 versus 275 nM). Conversely, SCaM-4 was >4-fold better than SCaM-1 in the activation of nitric-oxide synthase, a 1-8-14-type enzyme (28). These positive correlations further support the biological relevance of our findings.

Previously, two other groups (39, 40) reported isolating CaM-binding sequences using similar strategies. Dedman et al. (39) pioneered this type of work using a random 15-mer library, shorter than the typical CaM-binding domains, to screen for CaM-binding peptides. Among the 28 isolated peptides, Trp was always present and often (11 peptides) present in the first variable position of the random peptide inserts. Additionally, 17 of the peptides contained Trp-Pro sequences. Nevalainen et al. (40) used a random 8-mer peptide library and similarly found the Trp residue and the Trp-Pro combination in the isolated CaM-binding peptides. Because they used a random peptide library consisting of lengths shorter than those of the naturally occurring CaM-binding sequences, the peptides binding to CaM might be the flanking amino acid sequences present in the vector, potentially posing a significant bias. In this regard, the 22-mer random peptide library used in this study has merit over those peptides possessing pre-determined constraints, and it is also long enough to span the length of the hydrophobic binding surface of CaM. These advantages might prove useful in the isolation of CaM-binding sequences that are more like naturally occurring CaM-binding peptides. The majority of the 30 plus CaM-binding domains identified thus far consists of stretches of 16-35 amino acid residues. Of the 33 peptides isolated in this study, Trp residues are found present at random positions (6 of them are actually devoid of the Trp residue), and only two of the peptides (i.e. alpha 12 and beta 16) contain the Trp-Pro configuration. In addition, the 1-5-10 and 1-8-14 consensus motifs found in this study were originally identified in natural CaM-binding sequences, further arguing that the peptides isolated in this study resemble naturally occurring sequences.

What is the importance of our findings in regard to the structural perspective of the CaM-target peptide interaction? To address this, we built model structures of SCaM-1 bound to either M13 (of the 1-8-14 motif) or to the CaMKII CaM-binding sequence (of the 1-5-10 motif). The same models were prepared for SCaM-4. We then looked for any steric hindrance between SCaM and each of the peptides, hoping to discover any structural reason that would support our observation of the differential binding specificity. In short, we could not find any obvious reason that would clearly explain the basis of the binding discrimination of the SCaMs. However, we should note that this kind of modeling study assumes that both of the SCaM isoforms adopt the same conformation as that of target-bound mammalian CaM. Thus, the lack of a positive answer resulting from the model studies suggests two possibilities. First, SCaM isoforms may contain subtle differences in their side chain conformations of the residues directly interacting with target peptides despite the fact that their overall structures are similar to that of mammalian CaM. This would be similar to the structure of yeast CaM which is only 60% identical to mammalian CaM at the amino acid level (41). Indeed, we noticed that many Met residues in the SCaM isoforms were substituted for bulky hydrophobic amino acids such as Ile, Leu, and Val, which are involved in stabilizing the CaM-target peptide complex, by forming hydrophobic interactions and are also important for conferring flexibility to accommodate and recognize a wide range of targets (12). Alternatively, the overall structure of the SCaM isoforms might be different from that of mammalian CaM and may use different mechanisms for target binding than that of mammalian CaM. Therefore, only by high resolution three-dimensional structure determination of the complex with different peptides can the exact mechanism underlying the differential binding specificity of the SCaMs be determined.

The potential merits of this study are severalfold. First, the isolated CaM-binding sequences may serve as good references for searching for CaM-binding proteins in data bases or for mapping the CaM-binding domains of certain proteins. Second, these peptides may serve as useful tools for studying CaM isoform-specific functions in plant cells. For example, in regard to each other, Pep A and Pep B exhibit at least a 10-fold higher specificity for SCaM-1 and SCaM-4, respectively, in both gel overlay and PDE inhibition assays. Another advantage of these techniques is that one can study the function of CaM in different subcellular compartments by tagging the inhibitor peptide to various subcellular targeting sequences. For example, its nuclear function can be studied by fusing it to a nuclear localization signal (6). Currently these studies are underway in our laboratory.

    ACKNOWLEDGEMENTS

We are indebted to Dr. Mitsuhiko Ikura and Kyoko L. Yap (Department of Medical Biophysics, University of Toronto) for help in the modeling studies.

    FOOTNOTES

* This work was supported by Grant 2000-2-20900-001-1 from KOSEF, the National Research Laboratory (2000), and BK21 Program.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

** To whom correspondence should be addressed: Division of Applied Life Science, Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Chinju 660-701, Korea. Tel.: 82-55-751-5957; Fax: 82-55-759-9363; E-mail: mjcho@nongae.gsnu.ac.kr.

Published, JBC Papers in Press, March 18, 2002, DOI 10.1074/jbc.M110803200

2 Munich Information Center for Protein Sequences, mips.gsf.de/ proj/thal/.

    ABBREVIATIONS

The abbreviations used are: CaM, calmodulin; BSA, bovine serum albumin; HRP, horseradish peroxidase; gpIII, minor coat protein; PDE, 3',5'-cyclic nucleotide phosphodiesterase; SCaM, soybean calmodulin; TBS, Tris-buffered saline; TFE, 2,2,2-trifluoroethanol; GST, glutathione S-transferase; Mops, 4-morpholinepropanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lu, K. P., and Means, A. R. (1993) Endocr. Rev. 14, 40-58[CrossRef][Medline] [Order article via Infotrieve]
2. Crivici, A., and Ikura, M. (1995) Annu. Rev. Biophys. Biomol. Struct. 24, 85-116[CrossRef][Medline] [Order article via Infotrieve]
3. Bush, D. S. (1995) Annu. Rev. Plant Physiol. Plant Mol. Biol. 46, 95-122[CrossRef]
4. Snedden, W. A., and Fromm, H. (1998) Trends Plant Sci. 3, 299-304
5. Zielinski, R. E. (1998) Annu. Rev. Plant Physiol. Plant Mol. Biol. 49, 697-725[CrossRef]
6. Wang, J., Campos, B., Jamieson, G. A., Kaetzel, M. A., and Dedman, J. R. (1995) J. Biol. Chem. 270, 30245-30248[Abstract/Free Full Text]
7. Lee, A., Wong, S. T., Gallagher, D., Li, B., Storm, D. R., Scheuer, T., and Catterall, W. A. (1999) Nature 399, 155-159[CrossRef][Medline] [Order article via Infotrieve]
8. Liao, B., Paschal, B. M., and Luby-phelps, K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6217-6222[Abstract/Free Full Text]
9. Zuhlke, R. D., Pitt, G. S., Deisseroth, K., Tsien, R. W., and Reuter, M. (1999) Nature 399, 159-162[CrossRef][Medline] [Order article via Infotrieve]
10. Babu, Y. S., Bugg, C. E., and Cook, W. J. (1988) J. Mol. Biol. 204, 191-204[CrossRef][Medline] [Order article via Infotrieve]
11. O'Neil, K. T., and DeGrado, W. F. (1990) Trends Biochem. Sci. 15, 59-64[CrossRef][Medline] [Order article via Infotrieve]
12. Ikura, M., Clore, G. M., Gronenborn, A. M., Zhu, G., Klee, C. B., and Bax, A. (1992) Science 256, 632-638[Abstract/Free Full Text]
13. Meador, W. E., Means, A. R., and Quiocho, F. A. (1992) Science 257, 1251-1255[Abstract/Free Full Text]
14. Meador, W. E., Means, A. R., and Quiocho, F. A. (1993) Science 262, 1718-1721[Abstract/Free Full Text]
15. Afsha, M., Caves, L. S. D., Guimard, L., Hubbard, R. E., Calas, B., Grassy, G., and Haiech, J. (1994) J. Mol. Biol. 244, 554-571[CrossRef][Medline] [Order article via Infotrieve]
16. Yuan, T., Vogel, H. J., Sutherland, C., and Walsh, M. P. (1998) FEBS Lett. 431, 210-214[CrossRef][Medline] [Order article via Infotrieve]
17. Rhoads, A. R., and Friedberg, F. (1997) FASEB J. 11, 331-340[Abstract]
18. Yap, K. L., Kim, J., Truong, K., Sherman, M., Yuan, T., and Ikura, M. (2000) J. Struct. Funct. Genomics 1, 8-14[CrossRef][Medline] [Order article via Infotrieve]
19. Yang, T., Segal, G., Abbo, S., Fedman, M., and Fromm, H. (1996) Mol. Gen. Genet. 252, 684-694[Medline] [Order article via Infotrieve]
20. Poovaiah, B. W., Takezawa, D., An, G., and Han, T. I. (1996) J. Plant Physiol. 149, 553-558[Medline] [Order article via Infotrieve]
21. Gawienowski, M. C., Szymanski, D., Perera, I. Y., and Zielinski, R. E. (1993) Plant Mol. Biol. 22, 215-225[CrossRef][Medline] [Order article via Infotrieve]
22. Lee, S. H., Kim, J. C., Lee, M. S., Heo, W. D., Seo, H. Y., Yoon, H. W., Hong, J. C., Lee, S. Y., Bahk, J. D., Hwang, I., and Cho, M. J. (1995) J. Biol. Chem. 270, 21806-21812[Abstract/Free Full Text]
23. Falke, J. J., Drake, S. K., Hazard, A. L., and Peersen, D. B. (1994) Q. Rev. Biophys. 27, 219-290[Medline] [Order article via Infotrieve]
24. Lee, S. H., Kim, M. C., Heo, W. D., Kim, J. C., Chung, W. S., Park, C. Y., Park, H. C., Cheong, Y. H., Kim, C. Y., Lee, S., Lee, K. J., Bahk, J. D., Lee, S. Y., and Cho, M. J. (1999) Biochim. Biophys. Acta 1433, 56-67[CrossRef][Medline] [Order article via Infotrieve]
25. Heo, W. D., Lee, S. H., Kim, M. C., Kim, J. C., Chung, W. S., Chun, H. J., Lee, K. J., Park, C. Y., Park, H. C., Choi, J. Y., and Cho, M. J. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 766-771[Abstract/Free Full Text]
26. Cho, M. J., Vaghy, P. L., Kondo, R., Lee, S. H., Davis, J. P., Rehl, R., Heo, W. D., and Johnson, J. D. (1998) Biochemistry 37, 15593-15597[CrossRef][Medline] [Order article via Infotrieve]
27. Kondo, R., Tikunova, S. B., Cho, M. J., and Johnson, J. D. (1999) J. Biol. Chem. 274, 36213-36218[Abstract/Free Full Text]
28. Lee, S. H., Johnson, J. D., Walsh, M. P., Van Lierop, J. E., Sutherland, C., Xu, A., Snedden, W. A., Kosh-Kosicka, D., Fromm, H., Narayanan, N., and Cho, M. J. (2000) Biochem. J. 350, 299-306
29. Chung, W. S., Lee, S. H., Kim, J. C., Heo, W. D., Kim, M. C., Park, C. Y., Park, H. C., Lim, C. O., Kim, W. B., Harper, J. F., and Cho, M. J. (2000) Plant Cell 12, 1393-1407[Abstract/Free Full Text]
30. Pierce, H. H., Schachat, F., Brandt, P. W., Lombardo, C. R., and Kay, B. K. (1998) J. Biol. Chem. 273, 23448-23453[Abstract/Free Full Text]
31. Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve]
32. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning, A Laboratory Manual , 2nd Ed. , pp. 5.3-6.59, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
33. Lee, S. H., Seo, H. Y., Kim, J. C., Heo, W. D., Chung, W. S., Lee, K. J., Kim, M. C., Cheong, Y. H., Choi, J. Y., Lim, C. O., and Cho, M. J. (1997) J. Biol. Chem. 272, 9252-9259[Abstract/Free Full Text]
34. Bohm, G., Muhr, R., and Jaenicke, R. (1992) Protein Eng. 5, 191-195[Abstract/Free Full Text]
35. Erickson-Vittanen, S., and Degrado, W. F. (1987) Methods Enzymol. 139, 455-458[Medline] [Order article via Infotrieve]
36. Vogel, H. J. (1994) Biochem. Cell Biol. 72, 357-376[Medline] [Order article via Infotrieve]
37. Yuan, T., Weljie, A. M., and Vogel, H. J. (1998) Biochemistry 37, 3187-3195[CrossRef][Medline] [Order article via Infotrieve]
38. Keller, D., Clausen, R., Josefsen, K., and Led, J. J. (2001) Biochemistry 40, 10732-10740[CrossRef][Medline] [Order article via Infotrieve]
39. Dedman, J. R., Kaetzel, M. A., Chan, H. C., Nelson, D. J., and Jamieson, G. A. (1993) J. Biol. Chem. 268, 23025-23030[Abstract/Free Full Text]
40. Nevalainen, L. T., Aoyama, T., Ikura, M., Crivici, A., Yan, H., Chua, N. H., and Nairn, A. C. (1997) Biochem. J. 321, 107-115
41. Ishida, H., Takahashi, K., Nakashima, K., Kumaki, Y., Nakata, M., Hikichi, K., and Yazawa, M. (2000) Biochemistry 39, 13660-13668[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore